Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,727Revenue $M1,281Net Margin (%)-0.2Altman Z-Score5.5
Enterprise Value $M1,796EPS $-0.1Operating Margin %-0.7Piotroski F-Score6
P/E(ttm)--Beneish M-Score-3.1Pre-tax Margin (%)-0.0Higher ROA y-yN
Price/Book4.310-y EBITDA Growth Rate %--Quick Ratio1.0Cash flow > EarningsY
Price/Sales1.45-y EBITDA Growth Rate %--Current Ratio1.0Lower Leverage y-yY
Price/Free Cash Flow20.0y-y EBITDA Growth Rate %-49.2ROA % (ttm)-0.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-0.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M33.3ROIC % (ttm)-1.6Gross Margin Increase y-yY

Gurus Latest Trades with AMED

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMEDJoel Greenblatt 2015-12-31 Add0.09%$35.27 - $44.86
($40.1)
$ 51.8329%Add 151.78%345,912
AMEDJoel Greenblatt 2015-09-30 Reduce-0.08%$36.91 - $47.44
($42.19)
$ 51.8323%Reduce -65.25%137,387
AMEDJoel Greenblatt 2015-06-30 Add0.12%$25.42 - $42.34
($31.09)
$ 51.8367%Add 900.13%395,393
AMEDJoel Greenblatt 2015-03-31 Add$26.58 - $30.9
($28.21)
$ 51.8384%Add 69.32%39,534
AMEDJoel Greenblatt 2014-12-31 Buy 0.01%$19.59 - $30.07
($24.78)
$ 51.83109%New holding23,349
AMEDCharles Brandes 2014-12-31 Sold Out $19.59 - $30.07
($24.7)
$ 51.83110%Sold Out0
AMEDCharles Brandes 2014-09-30 Reduce-0.03%$15.58 - $21.78
($19.38)
$ 51.83167%Reduce -90.43%15,810
AMEDCharles Brandes 2014-03-31 Reduce-0.01%$14.09 - $16.96
($15.31)
$ 51.83239%Reduce -23.43%165,125
AMEDCharles Brandes 2013-03-31 Add0.03%$10.95 - $13.11
($11.61)
$ 51.83346%Add 515.74%225,885
AMEDJoel Greenblatt 2012-12-31 Sold Out -0.06%$9.65 - $13.56
($11.33)
$ 51.83357%Sold Out0
AMEDCharles Brandes 2012-12-31 Buy $9.65 - $13.56
($11.33)
$ 51.83357%New holding36,685
AMEDJoel Greenblatt 2012-09-30 Reduce-0.06%$11.3 - $15.84
($13.63)
$ 51.83280%Reduce -49.75%65,015
AMEDCharles Brandes 2012-09-30 Sold Out -0.0017%$11.3 - $15.84
($13.63)
$ 51.83280%Sold Out0
AMEDJoel Greenblatt 2012-03-31 Add0.09%$9.56 - $14.66
($11)
$ 51.83371%Add 98.71%144,813
AMEDCharles Brandes 2012-03-31 Buy $9.56 - $14.66
($11)
$ 51.83371%New holding20,195
AMEDDavid Dreman 2011-12-31 Sold Out -0.5%$9.59 - $14.56
($11.75)
$ 51.83341%Sold Out0
AMEDGeorge Soros 2011-12-31 Sold Out -0.0041%$9.59 - $14.56
($11.75)
$ 51.83341%Sold Out0
AMEDCharles Brandes 2011-12-31 Sold Out -0.0021%$9.59 - $14.56
($11.75)
$ 51.83341%Sold Out0
AMEDJoel Greenblatt 2011-09-30 Add0.09%$13.29 - $27.55
($19.78)
$ 51.83162%Add 125.99%64,379
AMEDGeorge Soros 2011-09-30 Reduce-0.07%$13.29 - $27.55
($19.78)
$ 51.83162%Reduce -91.93%16,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMED is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AMED: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
NORTH TIDE CAPITAL, LLC10% Owner 2015-11-03Sell217,580$39.9329.8view
NORTH TIDE CAPITAL, LLC10% Owner 2015-11-02Sell277,720$39.7930.26view
NORTH TIDE CAPITAL, LLC10% Owner 2015-10-28Sell191,400$39.8630.03view
WASHBURN DONALD ADirector 2015-08-18Sell20,000$45.5113.89view
Ginn Scott GSVP - Accounting & Controller 2015-08-07Sell3,063$46.3311.87view
PERKINS BRUCE DDirector 2015-07-31Buy3,000$43.0720.34view
RICCHIUTI PETERDirector 2015-05-05Sell900$27.6687.38view
JETER JEFFREY DChief Compliance Officer 2015-03-13Sell11,264$27.0291.82view
NETTERVILLE JACK LDirector 2015-03-13Sell10,000$27.290.55view
RICCHIUTI PETERDirector 2015-03-13Sell2,003$27.2590.2view

Quarterly/Annual Reports about AMED:

News about AMED:

Articles On GuruFocus.com
“Powerball” Ideas - Home Healthcare Companies: AFAM, GTIV, LHCG, AMED Jan 05 2012 
AMED: Investment Opportunity When the Price Hits an 8-Year Low Dec 27 2011 
Almost Family: The Magic Formula Stock is getting cheaper and cheaper Dec 11 2011 
Magic Formula Stock: Amedisys (AMED) Aug 05 2011 
Home Healthcare: Heavily Shorted long Opportunity May 30 2011 
Amedisys Inc (AMED) CFO Dale E Redman buys 1,000 Shares Aug 25 2010 
Amedisys Inc Reports Operating Results (10-Q) Aug 09 2010 
Amedisys Inc Reports Operating Results (10-Q) Apr 27 2010 
Amedisys Inc (AMED) Chairman of the Board William F Borne sells 25,000 Shares Feb 24 2010 
Amedisys Inc (AMED) Chairman of the Board William F Borne sells 12,500 Shares Dec 29 2009 

More From Other Websites
Q1 2016 Amedisys Inc Earnings Release - After Market Close May 03 2016
AMEDISYS INC Files SEC form 8-K, Entry into a Material Definitive Agreement May 02 2016
Amedisys Announces First Quarter Earnings Release and Conference Call Date Apr 26 2016
Amedisys Announces First Quarter Earnings Release and Conference Call Date Apr 26 2016
Amedisys Welcomes Three New Members To Its Board Of Directors Apr 26 2016
AMEDISYS INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles... Apr 26 2016
Amedisys Welcomes Three New Members To Its Board Of Directors Apr 26 2016
ETF’s with exposure to Amedisys, Inc. : April 19, 2016 Apr 19 2016
Amedisys Poised To Help Baby Boomers ‘Age In Place’ Apr 18 2016
Amedisys Poised on Balanced Growth, Strategic Buyouts Apr 12 2016
Looking for a Growth Stock? Why it is Time to Focus on Amedisys (AMED) Apr 08 2016
Amedisys Announces Clinical Excellence in Speech Language Pathology Mar 31 2016
Amedisys Announces Clinical Excellence in Speech Language Pathology Mar 31 2016
Amedisys, Inc. partners with Strategic Healthcare Programs (SHP) for insights to help enhance... Mar 30 2016
ETF’s with exposure to Amedisys, Inc. : March 29, 2016 Mar 29 2016
Can The Uptrend Continue for Amedisys (AMED)? Mar 15 2016
Amedisys, Inc. :AMED-US: Earnings Analysis: Q4, 2015 By the Numbers Mar 14 2016
Amedisys Strong on Strategic Buyouts, Hospice Market Trends Mar 11 2016
Strength Seen in Amedisys (AMED): Stock Soars 14.7% Mar 10 2016
AMEDISYS INC Files SEC form 10-K, Annual Report Mar 10 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)